Description
COVID longue
Lignes directrices canadiennes
Dernière mise à jour du 17 juillet 2025
Nouvelles publications scientifiques
- SSRI/SNRI and long COVID in children and adolescents with neuropsychiatric conditions: a cohort study from the RECOVER Initiativeon 24 août 2026
Nat Ment Health. 2026;4(8):1275-1284. doi: 10.1038/s44220-026-00675-9. Epub 2026 Jun 29.ABSTRACTLong COVID has been an important health concern in children and adolescents, yet factors associated […]
- Long-term angiogenic and thromboinflammatory signatures in post-COVID-19 syndromeon 24 août 2026
Angiogenesis. 2026 Aug 7;29(4):55. doi: 10.1007/s10456-026-10075-3.ABSTRACTBACKGROUND: Post-COVID-19 syndrome is a major long-term sequela of severe SARS-CoV-2 infection, potentially involving […]
- An interpretative phenomenological analysis study of perceptions around factors relating to coping amongst young people with Long Covid and mental health difficulties in the UKon 24 août 2026
Health Psychol Open. 2026 Aug 6;13:20551029261440419. doi: 10.1177/20551029261440419. eCollection 2026 Jan-Dec.ABSTRACTThe nature and causes of neuropsychiatric symptoms in children and young people […]
- Identifying EEG biomarkers of fatigue and brain fog in long COVID: insights from rest and movement-related brain activityon 24 août 2026
J Clin Neurosci. 2026 Aug 11;153:112230. doi: 10.1016/j.jocn.2026.112230. Online ahead of print.ABSTRACTBACKGROUND: Fatigue and brain fog are among the most reported symptoms in Long COVID (LC), yet […]
- Healthcare utilisation and cost among individuals with Long COVID in England and Wales: potential value of specialised post-COVID serviceson 24 août 2026
J R Soc Med. 2026 Aug 12:1410768261476537. doi: 10.1177/01410768261476537. Online ahead of print.ABSTRACTOBJECTIVE: To compare healthcare utilisation and costs for Long COVID (LC) in England and […]
- Functional impact of long Covid on work performance and return to work: a cross-sectional studyon 24 août 2026
Rev Saude Publica. 2026 Aug 17;60:e35. doi: 10.11606/s1518-8787.2026060007097. eCollection 2026.ABSTRACTOBJECTIVE: To evaluate the association between long Covid and socioeconomic, clinical, […]
- Longitudinal observation of persistent Long COVID symptoms and health-related quality of life in an adult German cohorton 24 août 2026
BMC Infect Dis. 2026 Aug 19;26(1):1529. doi: 10.1186/s12879-026-14252-z.ABSTRACTBACKGROUND: Many individuals experience persistent symptoms following an acute COVID-19 infection, a condition known as […]
- Cardiovascular, Renal, and Pulmonary Risks of Long COVID: A Retrospective Cohort Study Stratified by Age and Sexon 24 août 2026
J Am Heart Assoc. 2026 Aug 20:e049226. doi: 10.1161/JAHA.126.049226. Online ahead of print.ABSTRACTBACKGROUND: A substantial proportion of patients with acute COVID-19 develop postacute sequelae of […]
- Covid-19: 40% of affected healthcare workers had long covid, and a quarter still had symptoms after a yearon 24 août 2026
BMJ. 2026 Aug 20;394:e100628. doi: 10.1136/bmj-2026-100628.NO ABSTRACTPMID:42624521 | DOI:10.1136/bmj-2026-100628
- A cardiometabolic perspective on post-exertional malaise in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and Long COVIDon 24 août 2026
Cardiovasc Diabetol. 2026 Aug 20;25(1):250. doi: 10.1186/s12933-026-03316-8.ABSTRACTPost-exertional malaise (PEM), the defining feature of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), […]
- Virus reactivation in acute and long COVID-19on 24 août 2026
Nature. 2026 Aug 5. doi: 10.1038/s41586-026-10740-z. Online ahead of print.ABSTRACTChronic viral infections are ubiquitous in humans, with individuals carrying multiple viruses that can reactivate […]
- Rehabilitation in long COVID: a systematic review and meta-analysison 24 août 2026
ERJ Open Res. 2026 Aug 3;12(4):00133-2026. doi: 10.1183/23120541.00133-2026. eCollection 2026 Jul.ABSTRACTBACKGROUND: The long-term effects of rehabilitation in individuals with long COVID remain […]
- Changes in the role of nurses in the management of chronic conditions: a comparative qualitative analysis of registered nurses and nursing assistantson 24 août 2026
Soins. 2026 Jul-Aug;71(907):54-59. doi: 10.1016/j.soin.2026.06.018. Epub 2026 Jul 9.ABSTRACTThe increasing prevalence of chronic diseases, combined with healthcare professional shortage, makes a […]
- Can long COVID be prevented? Two drugs finally show promiseon 24 août 2026
Nature. 2026 Jul 29. doi: 10.1038/d41586-026-02341-7. Online ahead of print.NO ABSTRACTPMID:42527646 | DOI:10.1038/d41586-026-02341-7
- A call to educate: counteracting enacted stigma in children with long COVIDon 24 août 2026
Pediatr Res. 2026 Jul 28. doi: 10.1038/s41390-026-05315-7. Online ahead of print.NO ABSTRACTPMID:42521794 | DOI:10.1038/s41390-026-05315-7
- Integrated care pathway in individuals with Long COVID: STIMULATE-ICP, a cluster-randomized, phase 3 trialon 24 août 2026
Nat Med. 2026 Jul 28. doi: 10.1038/s41591-026-04552-x. Online ahead of print.ABSTRACTCombining multidisciplinary care plans into integrated care pathways (ICPs) is scalable, generalizable and […]
- Combining label-free Raman spectroscopy with machine learning to monitor COVID-19 disease from acute infection to recoveryon 24 août 2026
J Biomed Opt. 2026 Jul;31(7):077002. doi: 10.1117/1.JBO.31.7.077002. Epub 2026 Jul 20.ABSTRACTSIGNIFICANCE: Monitoring COVID-19 disease from acute infection to recovery is critical to understand […]
- Remdesivir and All-Cause Graft Loss Among Kidney Transplant Recipients With Symptomatic COVID-19on 24 août 2026
JAMA Netw Open. 2026 Jul 1;9(7):e2625591. doi: 10.1001/jamanetworkopen.2026.25591.ABSTRACTIMPORTANCE: The efficacy and safety of remdesivir for COVID-19 in kidney transplant (KT) recipients across […]
- Risks of autoimmune and inflammatory post-acute COVID-19 conditions: a network cohort study in six European countries, the USA and Koreaon 24 août 2026
BMJ Public Health. 2026 Jul 24;4(3):e001686. doi: 10.1136/bmjph-2024-001686. eCollection 2026.ABSTRACTOBJECTIVES: We aimed to assess the risk of incident autoimmune and inflammatory conditions during […]
- Convergent genetic and structural parameters of cardiovascular disease related insights of post-acute COVID-19on 24 août 2026
Biochem Biophys Res Commun. 2026 Jul 21;831:154319. doi: 10.1016/j.bbrc.2026.154319. Online ahead of print.ABSTRACTPost-Acute Sequelae of COVID-19 (PASC) is increasingly associated with long-term […]
Maladie de Lyme
- HHS launches initiatives to reduce Lyme diseaseon 24 août 2026
Am J Nurs. 2026 Sep 1;126(9):15. doi: 10.1097/AJN.0000000000000368e. Epub 2026 Aug 20.NO ABSTRACTPMID:42619194 | DOI:10.1097/AJN.0000000000000368e
- Synergistic drivers of Lyme disease emergence in North America: an eco-syndemic reviewon 24 août 2026
Geospat Health. 2026 Jul 23;21(2). doi: 10.4081/gh.2026.1479. Epub 2026 Aug 4.ABSTRACTLyme disease is a growing public health threat driven by interplay of climatic, ecological and social factors. […]
- Findings From Electronic Medical Record Review of 2500 Patients Identified With Lyme Disease Diagnoses, Test Orders, and Antibiotic Orders in the SubLyme Networkon 24 août 2026
Open Forum Infect Dis. 2026 Aug 6;13(8):ofag468. doi: 10.1093/ofid/ofag468. eCollection 2026 Aug.ABSTRACTBACKGROUND: Electronic health records provide opportunities for improving Lyme disease […]
- A cofactor-promiscuous HMGR from the Lyme disease pathogen illuminates diversity in bacterial isoprenoid biosynthesison 24 août 2026
Protein Sci. 2026 Sep;35(9):e70766. doi: 10.1002/pro.70766.ABSTRACTThe Lyme disease pathogen Borrelia burgdorferi contains a highly reduced genome lacking many primary metabolic pathways. However, B. […]
- Diagnostic challenges in an atypical presentation of Lyme neuroborreliosison 24 août 2026
BMJ Case Rep. 2026 Aug 17;19(8):e270816. doi: 10.1136/bcr-2025-270816.ABSTRACTA man in his early 70s presented with back pain, sleep disturbances, ataxia and confusion, which was initially diagnosed […]
- The ecology of Lyme disease: Long-term data, surprises, and a synthesison 24 août 2026
Proc Natl Acad Sci U S A. 2026 Aug 25;123(34):e2610907123. doi: 10.1073/pnas.2610907123. Epub 2026 Aug 17.ABSTRACTRisk of human exposure to Lyme disease and other tick-borne zoonoses is affected by […]
- Exploring data-driven algorithms to identify Lyme disease cases in electronic health recordson 24 août 2026
PLoS One. 2026 Aug 12;21(8):e0349121. doi: 10.1371/journal.pone.0349121. eCollection 2026.ABSTRACTA tool capable of quickly and accurately identifying Lyme disease (LD) cases in endemic areas would […]
- Will New Lyme Disease Approaches Change Patient Care?on 24 août 2026
JAMA. 2026 Aug 7. doi: 10.1001/jama.2026.15548. Online ahead of print.NO ABSTRACTPMID:42566225 | DOI:10.1001/jama.2026.15548
- Colonization of 3D-organotypic human skin by the Lyme Disease pathogen, Borrelia burgdorferion 24 août 2026
bioRxiv [Preprint]. 2026 Jul 21:2026.07.20.739593. doi: 10.64898/2026.07.20.739593.ABSTRACTBorrelia burgdorferi is a bacterial pathogen transmitted by ticks that is the causative agent of Lyme […]
- Lyme disease should be notifiableon 24 août 2026
BMJ. 2026 Jul 30;394:e100386. doi: 10.1136/bmj-2026-100386.NO ABSTRACTPMID:42532587 | DOI:10.1136/bmj-2026-100386
- Therapeutic plasma exchange and immunomodulatory strategies in post-infectious syndromes: A review of immune dysregulation in PTLDS, long COVID, ME/CFS, and PANS/PANDASon 24 août 2026
Transfus Apher Sci. 2026 Aug;65(4):104482. doi: 10.1016/j.transci.2026.104482. Epub 2026 Jun 26.ABSTRACTPost-infectious syndromes including post-treatment Lyme disease syndrome (PTLDS), long COVID, […]
- Actualisation des approches et des protocoles diagnostiques pour la maladie de Lyme au Canada: Aperçu des stratégies de dépistage existantes et de leurs limitationson 24 août 2026
Can Fam Physician. 2026 Jul-Aug;72(7-8):e224-e231. doi: 10.46747/cfp.720708e224.ABSTRACTOBJECTIF: Présenter une actualisation de la situation relative aux approches et aux protocoles diagnostiques […]
- Tick-borne bacterial and protozoal pathogens in horses in Austria - A cross-sectional study on current and past infections and potential risk factorson 24 août 2026
Ticks Tick Borne Dis. 2026 Jul;17(4):102680. doi: 10.1016/j.ttbdis.2026.102680. Epub 2026 Jul 4.ABSTRACTTick-borne bacterial and protozoal pathogens are a major threat to equine health worldwide. In […]
- Regional and demographic patterns of seroprevalence of Borrelia burgdorferi IgG and IgM antibodies in blood donors in Austriaon 24 août 2026
Ticks Tick Borne Dis. 2026 Jul;17(4):102684. doi: 10.1016/j.ttbdis.2026.102684. Epub 2026 Jul 21.ABSTRACTKnowledge about the epidemiology of Lyme borreliosis in Austria remains limited. We conducted […]
- Serological testing for Lyme disease: current assays, diagnostic performance, and challengeson 24 août 2026
J Clin Microbiol. 2026 Jul 20:e0032226. doi: 10.1128/jcm.00322-26. Online ahead of print.ABSTRACTLyme disease, caused by Borrelia burgdorferi sensu lato, remains the most common vector-borne […]
- The current landscape and future directions of Lyme disease vaccineson 17 juillet 2026
Virulence. 2026 Jun 21:2690805. doi: 10.1080/21505594.2026.2690805. Online ahead of print.ABSTRACTLyme disease (LD) represents a significant public health challenge in North America and Eurasia. The […]
- Using Electronic Health Records to Enhance Lyme Disease Surveillance: Protocol for the SubLyme Networkon 17 juillet 2026
JMIR Res Protoc. 2026 Jul 8;15:e94921. doi: 10.2196/94921.ABSTRACTBACKGROUND: Lyme disease is the most common vector-borne illness in the United States. The limitations of traditional surveillance […]
- Single-step immunoblot tests with recombinant protein antigens for detecting IgG and IgM antibodies in Lyme diseaseon 17 juillet 2026
Microbiol Spectr. 2026 Jul 15:e0019926. doi: 10.1128/spectrum.00199-26. Online ahead of print.ABSTRACTSerodiagnosis is important in Lyme disease (LD). Until recently, this commonly required two […]
- Lyme Disease Knowledge, Attitudes, and Practices Among Surveyed Clinicians in Western North Carolina, 2022-2023on 2 juin 2026
Vector Borne Zoonotic Dis. 2026 May 23:15303667261453194. doi: 10.1177/15303667261453194. Online ahead of print.ABSTRACTINTRODUCTION: Lyme disease has expanded into western North Carolina. We sought […]
- Lyme disease as a rare trigger for autoimmune hemolytic anemiaon 15 mai 2026
Lyme disease, caused by Borrelia burgdorferi, is a zoonotic infection affecting the skin, nervous system, joints, and heart. Diagnosis relies on clinical history, symptoms, and a two steps serologic […]
Encéphalomyélite myalgique
- Guidance on Home-Based Care for People with Severe ME/CFS: A Transdisciplinary Expert Statementon 24 août 2026
Wien Med Wochenschr. 2026 Aug;176(Suppl 1):28-51. doi: 10.1007/s10354-026-01182-3. Epub 2026 Jul 29.ABSTRACTBACKGROUND: Many patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) […]
- Central origin of fatigability in Myalgic encephalomyelitis/chronic fatigue syndrome revealed by multimodal neuroimagingon 24 août 2026
Neuroimage Clin. 2026 Jul 28;51:104041. doi: 10.1016/j.nicl.2026.104041. Online ahead of print.ABSTRACTMyalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a debilitating chronic disease […]
- Efficacy and Safety of Enzyme-Derived Deer Velvet Extract Supplementation on Adults with Chronic Fatigue: a Randomized, Placebo-Controlled, Double-Blind Trialon 24 août 2026
J Microbiol Biotechnol. 2026 Jul 9;36:e2601055. doi: 10.4014/jmb.2601.01055.ABSTRACTChronic Fatigue Syndrome (CFS) significantly impairs health-related quality of life in working-age populations, […]
- A Standardized Copper Bian-Stone Gua Sha Protocol for Treating Chronic Fatigue Syndrome in Human Subjectson 24 août 2026
J Vis Exp. 2026 Jul 3;(233). doi: 10.3791/70472.ABSTRACTChronic fatigue syndrome (CFS) is characterized by persistent, unexplained fatigue lasting six months or longer. This protocol describes a […]
- Multimodal approach to identify neuropsychophysiological subgroups in myalgic encephalomyelitis/chronic fatigue syndrome and their relevance for rehabilitation: protocol for a mechanistic cross-sectional and longitudinal studyon 24 août 2026
Brain Behav Immun Health. 2026 Jul 6;56:101299. doi: 10.1016/j.bbih.2026.101299. eCollection 2026 Oct.ABSTRACTINTRODUCTION: Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS) is a […]
- PTPRN2 hypomethylation and PHB2-associated miR-153-3p maturation define dual epigenetic features linked to symptom variability in Myalgic encephalomyelitison 17 juillet 2026
Author Names: Chalder, L.,Elremaly, W.,Caraus, I.,Leveau, C.,Franco, A.,Nepotchatykh, E.,Rostami-Afshari, B.,Gimenez, M.,Li, D.,Fang, Y.,Elbakry, M.,Godbout, C.,Di Tomasso, G.,Legault, […]
- Multimodal approach to identify neuropsychophysiological subgroups in myalgic encephalomyelitis/chronic fatigue syndrome and their relevance for rehabilitation: protocol for a mechanistic cross-sectional and longitudinal studyon 17 juillet 2026
Author Names: Dooms, Y.,Qiu, L.,Van Den Houte, M.,Coppieters, I.,Vergaelen, E.,Claes, S.,Dupont, P.,Cuypers, K.,Engler, H.,Dombrowski, K.,Verbeke, K.,Van den Bergh, O.,Bogaerts, K.,Raes, J.,Van […]
- Association between light exposure patterns and multidimensional health outcomes in individuals with myalgic encephalomyelitis/chronic fatigue syndrome: findings from an observational cross-sectional cohort studyon 17 juillet 2026
J Transl Med. 2026 Jul 3. doi: 10.1186/s12967-026-08556-6. Online ahead of print.ABSTRACTBACKGROUND: Light is a major environmental factor regulating circadian rhythms, sleep- wake cycles, and […]
- Tryptophan Metabolism and Aryl-Hydrocarbon Receptor Agonists in the Gut Microbiome of People With Myalgic Encephalomyelitis/Chronic Fatigue Syndromeon 17 juillet 2026
Microbiologyopen. 2026 Jun;15(3):e70333. doi: 10.1002/mbo3.70333.ABSTRACTMyalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a debilitating chronic disease with unknown biological basis […]
- Effectiveness of adapted physical activity and therapeutic exercise programme in improving chronic fatigue syndrome in long COVID, delivered via hospital-based rehabilitation versus telerehabilitationon 17 juillet 2026
Trials. 2026 Jun 17. doi: 10.1186/s13063-026-09769-2. Online ahead of print.ABSTRACTBACKGROUND: Long COVID is a prevalent condition characterised by pain, fatigue, disability, and a multitude of […]
- Components and Delivery Formats of Cognitive Behavioral Therapy for Chronic Fatigue Syndrome/Myalgic Encephalomyelitis: A Systematic Review and Component Network Meta-Analysison 2 juin 2026
Brain Behav. 2026 Jun;16(6):e71513. doi: 10.1002/brb3.71513.ABSTRACTOBJECTIVE: Chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) is a debilitating condition characterized by persistent […]
- Deficient TRPM3-linked mitochondrial Ca(2+) influx in natural killer cells associated with myalgic encephalomyelitis/chronic fatigue syndromeon 2 juin 2026
BMC Immunol. 2026 May 23. doi: 10.1186/s12865-026-00849-1. Online ahead of print.ABSTRACTINTRODUCTION: Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a multisystemic illness, commonly […]
- Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Successful Therapeutic Plasma Exchange Treatment After SARS-CoV-2 Infection-A Case Reporton 2 juin 2026
Clin Case Rep. 2026 May 17;14:e72725. doi: 10.1002/ccr3.72725. eCollection 2026 May.ABSTRACTMyalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complex neuroimmunological disorder […]
- Chronic fatigue syndrome in nursing practice: a concept analysison 2 juin 2026
BMC Nurs. 2026 May 15. doi: 10.1186/s12912-026-04749-y. Online ahead of print.ABSTRACTBACKGROUND: Nurses are essential in chronic fatigue syndrome (CFS) management, serving as care coordinators and […]
- Underuse of Pharmacologic Therapies for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Before Specialist Evaluationon 15 mai 2026
Ann Fam Med. 2026 Apr 29:250266. doi: 10.1370/afm.250266. Online ahead of print.ABSTRACTPURPOSE: Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a multisystem neurologic disease […]
- The efficacy of exercise in patients with myalgic encephalomyelitis/chronic fatigue syndrome: A systematic review and meta-analysison 15 mai 2026
J Psychosom Res. 2026 Apr 15;207:112677. doi: 10.1016/j.jpsychores.2026.112677. Online ahead of print.ABSTRACTOBJECTIVE: To evaluate the efficacy of exercise training for patients with myalgic […]
- Comparing ME/CFS following mononucleosis with Long COVIDon 15 mai 2026
Chronic Illn. 2026 Apr 15:17423953251347108. doi: 10.1177/17423953251347108. Online ahead of print.ABSTRACTObjectivesLong COVID following SARS-CoV-2 and Myalgic Encephalomyelitis/Chronic Fatigue […]
- Expert perspectives on Myalgic encephalomyelitis/chronic fatigue syndrome - Insights from the 3(rd) International Conference of the Charite Fatigue Centeron 10 avril 2026
Autoimmun Rev. 2026 Mar 25:104043. doi: 10.1016/j.autrev.2026.104043. Online ahead of print.ABSTRACTMyalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complex, multisystemic disorder […]
- Likely neurodivergence and variant connective tissue in patients with chronic pain/chronic fatigue: a case-control studyon 10 avril 2026
J Psychiatr Res. 2026 Jun;197:125-132. doi: 10.1016/j.jpsychires.2026.02.036. Epub 2026 Feb 18.ABSTRACTNeurodivergent traits are frequently observed in individuals with chronic pain and/or chronic […]
- Exercise interventions for physical function, psychological health, and quality of life in patients with myalgic encephalomyelitis/chronic fatigue syndrome and fibromyalgia: A systematic review and network meta-analysison 10 avril 2026
J Psychosom Res. 2026 Mar 5;206:112618. doi: 10.1016/j.jpsychores.2026.112618. Online ahead of print.ABSTRACTBACKGROUND: Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and fibromyalgia […]
CCAI
- Making Invisible Illnesses Visible: Recognizing and Responding to Infection-Associated Chronic Conditions - PubMedon 24 août 2026
The emergence of post-COVID conditions (PCCs) has renewed attention to infection-associated chronic conditions and illnesses (IACCIs), including myalgic encephalomyelitis/chronic fatigue syndrome […]
- Designing studies for post-treatment Lyme disease and other infection-associated chronic illnesses - PubMedon 17 juillet 2026
Infection-associated chronic illnesses (IACIs) encompass a spectrum of poorly understood syndromes often marked by significant neurologic and multisystem symptoms following an infectious event. This […]
- Persistent physical symptoms not explained by structural abnormalities or disease processes: a primary care approach to promote recovery - PubMedon 10 avril 2026
Background: A substantial proportion of people consulting primary care practitioners have symptoms that persist even after structural problems and diseases have been excluded. They experience […]
- Seeing the forest through the trees: Harmonizing infection-associated chronic illnesses researchon 16 mars 2026
Proc Natl Acad Sci U S A. 2026 Feb 24;123(8):e2600628123. doi: 10.1073/pnas.2600628123. Epub 2026 Feb 18.NO ABSTRACTPMID:41706889 | DOI:10.1073/pnas.2600628123
- Progress Toward Understanding Infection-Associated Chronic Conditions and Illnesses - PubMedon 6 février 2026
Display options Format AbstractPubMedPMID No abstract available Keywords: COVID-19; IACCI; Infection-associated chronic conditions and infections; Long COVID; bacteria; chronic fatigue syndrome; […]
- Long COVID as an Infection-Associated Chronic Condition: Implicationson 6 février 2026
Am J Health Promot. 2025 Jul;39(6):960-965. doi: 10.1177/08901171241308066b. Epub 2025 Jun 8.ABSTRACTA link between infection and chronic illness has been recognized, along with the complexities of […]
Études cliniques
- Post-acute Infectious Syndrome - Aripiprazole Symptom Evaluation (PAIS-AriSE)on 24 août 2026
Conditions: Post-acute Infectious Syndrome (PAIS); Post-COVID-19 Condition (PCC or Long COVID) Interventions: Drug: Aripiprazole (low-dose, 1mg); Drug: Placebo Sponsors: Christiana Franke Not yet […]
- Development of an Accessible Cognitive Behavioral Therapy Digital Therapeutic for Individuals With Long COVIDon 24 août 2026
Conditions: Long Covid; Depression; Anxiety Interventions: Device: Rauha® Digital Therapeutic Platform (Toivoa-004) Sponsors: Toivoa Inc; National Institute of Nursing Research (NINR) Withdrawn
- Different Treatment Options Used for Post Covid-19 Syndromeon 24 août 2026
Conditions: COVID-19; Post COVID-19 Syndrome; Ginkgo Biloba; Piracetam Interventions: Drug: Ginkgo biloba; Drug: Piracetam; Drug: Ginkgo biloba and Piracetam Sponsors: Beni-Suef University […]
- Micro-choice-based Intervention for Multicausal Fatigueon 24 août 2026
Conditions: Multicausal Fatigue; Fatigue; Post COVID Condition; Long COVID Syndrome; Postviral Fatigue Interventions: Behavioral: Micro-choice-based intervention Sponsors: University Hospital, […]
- CD19-B Cell Depletion in PAIS-ME/CFS Patientson 24 août 2026
Conditions: Post-acute Infectious Syndrome (PAIS); Post-COVID 19 Condition (PCC or Long COVID); Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Interventions: Drug: Inebilizumab; Drug: […]
- Kinesiotaping Versus Physiotherapy for Post-Covid-19 Back Painon 24 août 2026
Conditions: Post-COVID-19 Syndrome; Back Pain; Musculoskeletal Pain Interventions: Device: Kinesiotaping; Procedure: Conventional Physiotherapy Sponsors: Medipol University Completed
- A Study to Learn About the Study Medicine Paxlovid (Nirmatrelvir + Ritonavir) in Adults Aged 60 and Older Living in Korean Long-term Care Hospitals Who Have COVID-19on 24 août 2026
Conditions: Coronavirus Disease 2019 (COVID-19) Interventions: Drug: Nirmatrelvir/Ritonavir Sponsors: Pfizer Completed
- Five-year Follow-up After Sars-CoV-2 Infection: Prevalence and Evolution of Post-acute Sequalae of COVID-19 (PASC)on 24 août 2026
Conditions: Long COVID; COVID-19; Post-Acute COVID-19 Syndrome; Post-Acute COVID-19 Infection; Post-Acute COVID-19 Interventions: Other: Post-Acute Sequelae of COVID-19 (PASC) Assessment Sponsors: […]
- Validation of Biomarkers for Long COVID in the LIINC Viral Immunopathogenesis and Persistence Repeat Donor Cohort (VIPER)on 24 août 2026
Conditions: Long Covid Sponsors: University of California, San Francisco; PolyBio Research Foundation Recruiting
- Fatigue Investigation Using Digital Outcomeson 24 août 2026
Conditions: Multiple Sclerosis; Long Covid; Healthy Sponsors: Liliana Barrios; ETH Zurich (Switzerland); Centre Suisse d'Electronique et de Microtechnique (CSEM), Switzerland; Innosuisse - Swiss […]
- Long-Term Study of COVID-19 Infection and Long COVIDon 24 août 2026
Conditions: SARS CoV-2 Post-Acute Sequelae Interventions: Other: This study is observational. Only patients who have previously tested positive for SARS-CoV-2 infection or are experiencing ongoing […]
- Fully Remote, Telehealth-based Ketogenic Metabolic Therapy for Long COVIDon 24 août 2026
Conditions: Long COVID Fatigue Interventions: Other: Ketogenic Metabolic Therapy; Behavioral: Lifestyle Intervention Sponsors: National University of Natural Medicine Completed
- Epigenetic Changes in Long COVID Patientson 24 août 2026
Conditions: Long COVID-19 Syndrome; Long COVID Symptoms Sponsors: Istituti Clinici Scientifici Maugeri SpA; IRCCS Ospedale San Raffaele; Istituto Auxologico Italiano Not yet recruiting
- Nutritional Intervention and Rehabilitation Treatment in Patients With Post-COVID Conditionon 17 juillet 2026
Conditions: Post-COVID Condition Interventions: Dietary Supplement: Active; Other: Placebo Sponsors: Instituto de Investigación Sanitaria Aragón; Solutex GC S.L. Completed
- LYT-100 in Post-acute COVID-19 Respiratory Diseaseon 17 juillet 2026
Conditions: Covid19; Post-acute COVID-19 Respiratory Disease Interventions: Drug: LYT-100; Other: Placebo Sponsors: PureTech; Clinipace Worldwide; Novotech (Australia) Pty Limited Terminated
- Taurine Supplementation in Adolescents With Post-COVID Conditionon 17 juillet 2026
Conditions: Long COVID; Post COVID-19 Condition; PASC Post Acute Sequelae of COVID 19 Interventions: Drug: Taurine Sponsors: University of Alberta; Canadian Institutes of Health Research (CIHR) […]
- A Pilot Randomized Controlled Trial of Homeopathic Treatment for Long COVIDon 17 juillet 2026
Conditions: Long COVID; Long COVID Symptoms Interventions: Other: Treatment A: Treatment by a homeopath prescribing a specific homeopathic remedy for long COVID; Other: a course of individually […]
- Fatigue in Long COVIDon 17 juillet 2026
Conditions: Long COVID Interventions: Behavioral: Lightning Process; Other: Activity Pacing Sponsors: McMaster University; Hamilton Academic Health Sciences Organization Not yet recruiting
- Transcranial Direct Current Stimulation for Long COVID Brain Fog and Fatigueon 17 juillet 2026
Conditions: Long COVID; Post-COVID Conditions; Fatigue; Cognitive Dysfunction Interventions: Device: Transcranial Direct Current Stimulation Sponsors: University of Las Palmas de Gran Canaria; […]
- The Efficacy of Long-Chain Fatty Acids, Eicosapentaenoic Acid (EPA) and Specialized Pro-Resolving Mediators (SPMs), in Treating Long COVID Neuropsychiatric Symptoms: A Double-Blind Placebo-Controlled Clinical Trial and Analysis of Inflammatory Markers and Microbiomeon 17 juillet 2026
Conditions: COVID - 19; Depression - Major Depressive Disorder Interventions: Dietary Supplement: Eicosapentaenoic acid (omega-3 fatty acid); Dietary Supplement: Specialized Pro-Resolving Lipid […]
Formation continue
- Canadian Tick-Borne Disease Conferenceon 17 juillet 2026
Join us for the second annual Canadian Tick-Borne Disease Conference exclusively for medical practitioners. Taking place in Toronto, the CTD Conference will allow you to hear the latest on […]
- 2026 Symposiumon 17 juillet 2026
Long COVID Web is pleased to announce the 4th Canadian Symposium on Long COVID. The Symposium will bring together people with lived experience of Long COVID, clinicians, trainees, allied health, […]
- Canadian Symposium on Long COVID - Institute of Health Policy, Management and Evaluationon 17 juillet 2026
On behalf of Long COVID Web… Registration is now open for the 4th Canadian Symposium on Long COVID, co-organized by Long COVID Web in collaboration with local planning committee members. The […]
- 4th Long COVID International Conference 2026on 17 juillet 2026
This conference aims to raise awareness, clarify misconceptions, promote understanding, and stimulate discussion amongst healthcare professionals, investigators, policymakers, and community […]
- 3rd Long COVID International Conference 2025on 15 mai 2026
- 3rd Canadian Symposium on Long COVID | Cross-Pillar Discussionon 15 mai 2026
This closing session brings together voices from research, clinical practice, and lived experience to reflect on the key insights and lessons shared throughout the 3rd Canadian Symposium on Long […]
- ISLC-PAIS Conference 2026 in Amsterdamon 15 mai 2026
26 – 29 August, 2026 Amsterdam (the Netherlands) Join Lionhearted ScienceUnited Against Long COVID & PAIS Post-Acute Infection Syndromes (PAIS), including Long COVID, are among the most […]
- 4th Long COVID International Conference 2026on 15 mai 2026
This conference aims to raise awareness, clarify misconceptions, promote understanding, and stimulate discussion amongst healthcare professionals, investigators, policymakers, and community […]
- International ME/CFS Conference 2026on 10 avril 2026
Under the stewardship of Prof Carmen Scheibenbogen, Director of the Division of Immunodeficiencies and Post-infectious Diseases and the Charité Fatigue Center (CFC) at Charité – […]
- 2025 Symposiumon 10 avril 2026
Emera Innovation Exchange, Signal Hill Campus, Memorial University St. John’s, Newfoundland. Background Long Covid Web and Memorial University of Newfoundland are pleased to announce the […]
- Entrez dans le labyrinthe de Lyme - Radio-Canadaon 16 mars 2026
Entrez dans le labyrinthe de Lyme Radio-Canada
- 2026_Program_LTBDI_Symposium.pdfon 6 février 2026
- Looking at the Pandemic in the Rearview Mirror: Successes, Failures and Unintended Consequences. Conference, May 2025.on 6 février 2026
Supporting the generation of high-quality evidence for public health emergencies. Fostering effective and efficient knowledge exchange for global public health emergencies. Inspiring policymakers […]
- 2026 International Forum on COVID Rehabilitation Researchon 6 février 2026
Rob Wüst is an Associate Professor at the Faculty of Behavioral and Movement Sciences at the Vrije Universiteit Amsterdam. His research group studies skeletal and cardiac muscle metabolism and […]
- 2026 Symposiumon 6 février 2026
Long Covid Web and the University of British Columbia are pleased to announce the 2026 Canadian Symposium on Long COVID. The Symposium will bring together people with lived experience of Long COVID, […]
Revue d'actualités
- Maladie de Lyme : bientôt un test rapide à la maison - BFMon 24 août 2026
Maladie de Lyme : bientôt un test rapide à la maison BFM
- Éditorial de Claudine St-Germain | Partons en guerre contre les tiques - Le Devoiron 24 août 2026
Éditorial de Claudine St-Germain | Partons en guerre contre les tiques Le Devoir
- Les tiques se sont installées pour de bon dans les parcs montréalais - ledevoir.comon 24 août 2026
Les tiques se sont installées pour de bon dans les parcs montréalais ledevoir.com
- Anaplasmose | Une vie changée après avoir été infecté par une tique - La Presseon 24 août 2026
Anaplasmose | Une vie changée après avoir été infecté par une tique La Presse
- Les Montréalais ne sont pas à l’abri de la maladie de Lyme - Radio-Canadaon 24 août 2026
Les Montréalais ne sont pas à l’abri de la maladie de Lyme Radio-Canada
- Une allergie à la viande transmise par les tiques - La Presseon 24 août 2026
Une allergie à la viande transmise par les tiques La Presse
- Six ans après la pandémie, que deviennent les malades du Covid long ? - rts.chon 24 août 2026
Six ans après la pandémie, que deviennent les malades du Covid long ? rts.ch
- Une perturbation du rythme circadien associée à un risque plus élevé de COVID longue - Noovo Infoon 24 août 2026
Une perturbation du rythme circadien associée à un risque plus élevé de COVID longue Noovo Info
- Comment les tiques transmettent-elles des maladies en forêt? - Le Devoiron 17 juillet 2026
Comment les tiques transmettent-elles des maladies en forêt? Le Devoir
- Les spécialistes lancent un avertissement : cette maladie transmise par les tiques augmente rapidement au Québec et ses symptômes ressemblent à une simple grippe - Salut Bonjouron 17 juillet 2026
Les spécialistes lancent un avertissement : cette maladie transmise par les tiques augmente rapidement au Québec et ses symptômes ressemblent à une simple grippe Salut Bonjour
- Mordue par une tique, elle devient allergique à la viande - Radio-Canadaon 17 juillet 2026
Mordue par une tique, elle devient allergique à la viande Radio-Canada
- Les tiques gagnent du terrain dans nos régions - Radio-Canadaon 17 juillet 2026
Les tiques gagnent du terrain dans nos régions Radio-Canada
- La maladie de Lyme bat des records à Montréal - Le Journal de Montréalon 2 juin 2026
La maladie de Lyme bat des records à Montréal Le Journal de Montréal
- Bientôt un vaccin contre les maladies transmises par les tiques? - Radio-Canadaon 2 juin 2026
Bientôt un vaccin contre les maladies transmises par les tiques? Radio-Canada
- Lyme disease cases in England rise 20% in a yearon 2 juin 2026
BMJ. 2026 May 26;393:e180319. doi: 10.1136/bmj-2026-180319.NO ABSTRACTPMID:42191169 | DOI:10.1136/bmj-2026-180319
- Long Covid Service Extended to Cover Wider Range of Conditions - NHS Forth Valleyon 15 mai 2026
Long Covid Service Extended to Cover Wider Range of Conditions NHS Forth Valley
- Long COVID: 3 years in - The Lanceton 15 mai 2026
Long COVID: 3 years in The Lancet
- Une experte déplore l’arrêt du rapport provincial sur la surveillance des tiques - Radio-Canadaon 15 mai 2026
Une experte déplore l’arrêt du rapport provincial sur la surveillance des tiques Radio-Canada
- Designing Nutrition Studies for Long COVID and Related Infection-Associated Chronic Illness: Qualitative Insights From a Patient-Reported Evaluation of Ketogenic Metabolic Therapyon 15 mai 2026
J Patient Exp. 2026 Apr 13;13:23743735261442541. doi: 10.1177/23743735261442541. eCollection 2026.ABSTRACTBACKGROUND: Long COVID affects over 400 million people worldwide and has no FDA-approved […]
- COVID longue | Une équipe de l’IRCM est sur une nouvelle piste - La Presseon 15 mai 2026
COVID longue | Une équipe de l’IRCM est sur une nouvelle piste La Presse
Pour obtenir les documents
L’accès au texte intégral des documents est restreint au personnel et aux médecins du CHUM en fonction des abonnements de la bibliothèque. Certains documents sont en accès libre sur le web.
Si vous êtes branchés sur le réseau CHUM :
Cliquer sur les liens fournis pour chaque référence pour vérifier la disponibilité du texte intégral.
Pour les articles provenant de PubMed, cliquer préalablement sur le lien suivant pour afficher la disponibilité du document.
Si vous êtes dans un autre établissement et que vous n’arrivez pas à accéder au texte intégral d’un article à partir du lien donné, vérifier auprès de la bibliothèque de votre institution en donnant la référence complète du document.
|
Avis de non-responsabilité
Le contenu des veilles informationnelles ou stratégiques (ci-après appelée « Veilles ») est mis à votre disposition à titre informatif pour un usage personnel exclusif. Tout usage commercial du contenu des Veilles est strictement interdit. Tous les éléments, articles, rapports ou toute autre source d’information figurant dans les Veilles, vous sont fournis « tels quels », sans garantie d’aucune sorte. Eu égard aux propos tenus dans les articles et les rapports sélectionnés pour les Veilles, le CHUM n’offre aucune garantie notamment d’exhaustivité, de fiabilité, d’actualité et d’exactitude.Le CHUM ne pourra en aucun cas être tenu responsable envers quiconque de tout dommage quel qu’il soit, même ceux directs, encouru notamment des suites de toute réclamation, action ou poursuite découlant, même directement, de l’utilisation de ces Veilles.
Les Veilles contiennent des liens vers des sites Web créés et mis à jour par des tierces parties. Ces liens sont fournis pour la commodité des utilisateurs seulement. Le CHUM n’endosse et ne garantit, ni explicitement ni implicitement, l’exactitude ou l’intégralité ni du contenu de ces hyperliens ni des opinions qui y sont exprimées. Le CHUM n’assume aucune responsabilité à l’égard de ces sites Web externes.
Le CHUM prend tous les moyens raisonnables afin de respecter les droits de propriété intellectuelle afférents au contenu des Veilles et aux modalités du prêt entre bibliothèques, émises par l’Université de Montréal. Le contenu des Veilles, incluant la manière dont il est présenté, sont notamment protégés par la Loi sur le droit d’auteur (L.R.C. (1985), ch. C-42). Le CHUM ne donne aucune garantie et ne fait aucune déclaration à l’effet que le contenu de ces veilles n’enfreint aucun droit d’une autre personne ou entité. Le téléchargement, la reproduction en un seul exemplaire ou le tirage sur papier des Veilles ne sont autorisés qu’à des fins de sauvegarde et pour un usage privé et non commercial. Tout téléchargement, reproduction, édition, diffusion sur Internet, utilisation à des fins commerciales ou publiques, distribution, publication sur un autre site ou sur quelque autre forme ainsi que toute autre utilisation est strictement interdite, à moins d’être faite dans le respect des règles de propriété intellectuelle applicables. |


